[1]
2024. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: A multiparametric evaluation. Brazilian Journal of Pharmaceutical Sciences. 60, (Nov. 2024). DOI:https://doi.org/10.1590/.